Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T18:41:26.409Z.
Calculation as of: 2026-10-06T18:41:26.409Z.
Quote observation: 2026-10-06T18:40:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f97479f440d7a03605f533a56e26179237db48e588053495707f458dff3bcd44
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$5.02B
EV/EBITDA Ratio
15.01x
TTM Avg
15.80x
3Y Avg
19.63x
5Y Avg
19.63x
Market Cap
$5.05B
EV/EBITDA Ratio
16.08x
TTM Avg
15.97x
3Y Avg
19.93x
5Y Avg
21.74x
Market Cap
$5.14B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.80B
EV/EBITDA Ratio
N/A
TTM Avg
2239.52x
3Y Avg
2239.52x
5Y Avg
2239.52x
Market Cap
$5.18B
EV/EBITDA Ratio
247.91x
TTM Avg
297.42x
3Y Avg
297.42x
5Y Avg
297.42x
Market Cap
$4.72B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Erasca, Inc. (ERAS) | $4.98B | N/A | N/A | N/A | N/A |
| Waystar Holding Corp. (WAY)vs › | $5.02B | 15.01x | 15.80x | 19.63x | 19.63x |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.05B | 16.08x | 15.97x | 19.93x | 21.74x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.14B | N/A | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.81B | N/A | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.80B | N/A | 2239.52x | 2239.52x | 2239.52x |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.18B | 247.91x | 297.42x | 297.42x | 297.42x |
| Cogent Biosciences, Inc. (COGT)vs › | $5.17B | N/A | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.72B | N/A | N/A | N/A | N/A |
| Sotera Health Company (SHC)vs › | $5.23B | 12.48x | 12.96x | 13.18x | 14.62x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
